Logo image of CLVR

CLEVER LEAVES HOLDINGS INC (CLVR) Stock Price, Quote, News and Overview

NASDAQ:CLVR - Nasdaq - CA1867602031 - Common Stock - Currency: USD

3  +0.89 (+42.18%)

After market: 3.05 +0.05 (+1.67%)

CLVR Quote, Performance and Key Statistics

CLEVER LEAVES HOLDINGS INC

NASDAQ:CLVR (5/16/2024, 8:00:00 PM)

After market: 3.05 +0.05 (+1.67%)

3

+0.89 (+42.18%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week High8.4
52 Week Low1.38
Market Cap5.25M
Shares1.75M
Float1.54M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)08-12 2024-08-12/amc
IPO12-18 2020-12-18


CLVR short term performance overview.The bars show the price performance of CLVR in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 -20 40 60

CLVR long term performance overview.The bars show the price performance of CLVR in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of CLVR is 3 USD. In the past month the price decreased by -26.74%. In the past year, price decreased by -60.1%.

CLEVER LEAVES HOLDINGS INC / CLVR Daily stock chart

CLVR Latest News and Analysis

News Image
4 months ago - Benzinga

Cannabis Flower Sales In Colombia And The Small Producer Protection Myth: Ex-Official Says Most Companies Qualify

Colombia's cannabis decree allows dry flower sales, but ex-official claims it won't just protect small producers—most companies may qualify.

News Image
5 months ago - Benzinga

Cannabis Companies Delisted From Major Stock Exchanges In 2024: What Went Wrong?

Several cannabis companies faced delisting in 2024, including Bright Green and Aurora, due to financial struggles. Learn what happened here..

News Image
9 months ago - InvestorPlace

Stock Market Crash Warning: Don’t Get Caught Holding These 3 Cannabis Stocks

Cannabis stocks are soaring amid potential rescheduling of the drug. But these three cannabis stocks are still in deep trouble regardless.

News Image
10 months ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Pre-market stock movers are a great way to start the week as we check out all of the biggest news moving shares on Monday!

News Image
10 months ago - Clever Leaves

Clever Leaves Announces Voluntary Delisting and SEC Deregistration

TOCANCIPÁ, Colombia, April 26, 2024 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a...

News Image
10 months ago - InvestorPlace

CLVR Stock Earnings: Clever Leaves Holdings Misses Revenue for Q4 2023

CLVR stock results show that Clever Leaves Holdings missed on revenue for the fourth quarter of 2023.

CLVR Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 67.56 833.80B
NVO NOVO-NORDISK A/S-SPONS ADR 27.18 383.72B
JNJ JOHNSON & JOHNSON 15.33 368.65B
AZN ASTRAZENECA PLC-SPONS ADR 19.94 223.25B
MRK MERCK & CO. INC. 11.42 220.79B
NVS NOVARTIS AG-SPONSORED ADR 13.55 212.44B
PFE PFIZER INC 8.28 145.87B
SNY SANOFI-ADR 13.44 133.76B
BMY BRISTOL-MYERS SQUIBB CO 49.87 115.30B
ZTS ZOETIS INC 29.76 77.34B
GSK GSK PLC-SPON ADR 7.82 73.53B
TAK TAKEDA PHARMACEUTIC-SP ADR 30.75 42.89B

About CLVR

Company Profile

CLVR logo image Clever Leaves Holdings Inc is a CO-based company operating in Pharmaceuticals industry. The company employs 400 full-time employees The company went IPO on 2020-12-18. Clever Leaves Holdings Inc. is a multinational operator and licensed producer of pharmaceutical-grade cannabinoids. The firm's segments include Cannabinoid and Non-Cannabinoid. The Cannabinoid segment is comprised of cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products. The Non-Cannabinoid operating segment is comprised of the brands and manufacturing assets acquired as part of its acquisition of Herbal Brands. The Non-Cannabinoid segment is engaged in the business of formulating, manufacturing, marketing, selling, distributing, and otherwise commercializing wellness products and nutraceuticals, excluding cannabinoid products. Its customers for the Herbal Brands products include specialty and health retailers, mass retailers and specialty and health stores in the United States. The company offers product portfolio in two categories: nutraceuticals and cannabinoids. The nutraceutical products consist of a variety of beverage and powder products.

Company Info

CLEVER LEAVES HOLDINGS INC

Bodega 19-B Parque Industrial Tibitoc Ph, Tocancipa - Cundinamarca

Boca Raton FLORIDA 10017 CO

CEO: Kyle Detwiler

Employees: 400

Company Website: https://cleverleaves.com/

Phone: 16468804382.0

CLVR FAQ

What is the stock price of CLVR?

The current stock price of CLVR is 3 USD.


What is the symbol for CLEVER LEAVES HOLDINGS INC stock?

The exchange symbol of CLEVER LEAVES HOLDINGS INC is CLVR and it is listed on the Nasdaq exchange.


On which exchange is CLVR stock listed?

CLVR stock is listed on the Nasdaq exchange.


Is CLVR a good stock to buy?

Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for CLVR, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of CLVR.


Does CLVR stock pay dividends?

CLVR does not pay a dividend.


When does CLVR stock report earnings?

CLVR will report earnings on 2024-08-12, after the market close.


What is the Price/Earnings (PE) ratio of CLVR?

CLVR does not have a PE ratio as the earnings reported over the last twelve months were negative (-11.4).


What is the Short Interest ratio of CLVR stock?

The outstanding short interest for CLVR is 0.55% of its float.


CLVR Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

CLVR Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to CLVR. Both the profitability and financial health of CLVR have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

CLVR Financial Highlights

Over the last trailing twelve months CLVR reported a non-GAAP Earnings per Share(EPS) of -11.4. The EPS decreased by 78.15% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -57.31%
ROE -73.94%
Debt/Equity 0.03
Chartmill High Growth Momentum
EPS Q2Q%85.01%
Sales Q2Q%0.61%
EPS 1Y (TTM)78.15%
Revenue 1Y (TTM)4.8%

CLVR Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 43% to CLVR. The Buy consensus is the average rating of analysts ratings from 6 analysts.

For the next year, analysts expect an EPS growth of 29.03% and a revenue growth 50% for CLVR


Ownership
Inst Owners2.55%
Ins Owners342.65%
Short Float %0.55%
Short Ratio0.13
Analysts
Analysts43.33
Price Target24.48 (716%)
EPS Next Y29.03%
Revenue Next Year50%